Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	69	33	27	33	69	44
Market Cap Growth	24.62%	24.62%	-17.94%	-52.77%	55.54%	-43.35%
Enterprise Value	72	37	27	31	59	37
Last Close Price	4.97	2.37	1.79	2.25	4.67	2.95
Forward PE	-	24.00	24.00	24.00	24.00	-
PS Ratio	1.85	0.88	0.68	0.78	1.92	1.18
PB Ratio	3.03	1.48	0.91	0.91	1.62	0.95
P/TBV Ratio	17.50	8.39	4.39	6.84	3.83	2.46
P/FCF Ratio	-	-	4.59	3.90	11.04	8.40
P/OCF Ratio	-	-	4.38	3.85	10.86	8.18
PEG Ratio	-	1.52	1.52	1.52	1.52	1.52
EV/Sales Ratio	1.90	0.98	0.67	0.73	1.65	0.99
EV/FCF Ratio	-	-	4.56	3.67	9.49	6.99
Debt / Equity Ratio	0.91	0.91	0.63	0.58	0.38	0.36
Debt / EBITDA Ratio	50.39	50.39	32.10	15.97	-	-
Debt / FCF Ratio	-	-	3.17	2.51	2.57	3.24
Asset Turnover	0.48	0.48	0.45	0.47	0.40	0.37
Inventory Turnover	1.53	1.53	0.84	1.00	0.92	0.89
Quick Ratio	0.94	0.94	1.00	1.15	1.76	1.45
Current Ratio	1.15	1.15	1.28	1.61	2.37	1.95
Return on Equity (ROE)	-24.88%	-24.88%	-19.41%	-14.38%	-12.51%	-13.53%
Return on Assets (ROA)	-5.11%	-5.11%	-4.44%	-4.02%	-5.30%	-3.97%
Return on Capital (ROIC)	-8.85%	-8.85%	-7.42%	-6.17%	-7.83%	-5.84%
Earnings Yield	-9.33%	-19.47%	-23.51%	-17.12%	-5.09%	-7.54%
FCF Yield	-0.98%	-2.04%	21.77%	25.66%	9.05%	11.91%
Buyback Yield / Dilution	1.67%	1.67%	1.82%	2.29%	1.70%	1.52%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q